MFSD2A potentiates gastric cancer response to anti‐PD‐1 immunotherapy by reprogramming the tumor microenvironment to activate T cell response
Article in Cancer Communications (August 2023)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Article in Cancer Communications (August 2023)
Article in Frontiers in Oncology (June 2023)
Article in Frontiers in Immunology (November 2022)